Skip to search.
 FTSE 100 Down 0.08%

Gilead Sciences Inc. (GILD)

-NasdaqGS
117.86 Down 0.04(0.03%) 31 Jul 21:00
|Pre-Market : 117.60 Down 0.26 (0.22%) 11:19
Add to Portfolio
Prev Close:117.90
Open:118.97
Bid:117.55 x 100
Ask:117.94 x 100
1y Target Est:128.21
Beta:0.88
Earnings Date:26 Oct - 30 Oct (Est.)
Day's Range:117.12 - 119.00
52wk Range:85.95 - 123.37
Volume:9,218,671
Avg Vol (3m):11,099,100
Market Cap:173.21b
P/E (ttm):13.44
EPS (ttm):8.77
Div & Yield:1.72 (1.50%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.03%173.21b
GSKDown 0.34%104.91b
PFEUp 0.92%222.05b
RHHBYUp 0.17%245.91b

Key Statistics

Forward P/E (1 yr):10.28
P/S (ttm):6.30
Ex-Dividend Date:12-Jun-15

Analysts

Annual EPS Est (Dec-15) :11.47
Quarterly EPS Est (Sep-15) :2.81
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.49

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback